quinazolines has been researched along with Bacterial Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, Y; Li, Y; Li, Z; Qu, J; Song, F; Zhao, L | 1 |
| Jiang, JJ; Jiang, KM; Jin, Y; Li, K; Lin, J; Shi, LP; Tao, YH; Wang, XH | 1 |
| Antypenko, LM; Fedyunina, NS; Karpenko, OV; Katsev, AM; Kovalenko, SI; Novikov, VP | 1 |
| Babu, R; Guda, R; Kasula, M; Kumar, G; Lingabathula, H; Muthadi, S; Narsimha, S; Palabindela, R; Yellu, NR | 1 |
| Antypenko, OM; Berest, GG; Katsev, AM; Kovalenko, SI; Nosulenko, IS; Shandrovskaya, OS; Voskoboynik, OY | 1 |
| Dame, C; Sutor, AH | 1 |
| Ceriani, I; Magri, V; Marras, E; Perletti, G; Trinchieri, A | 1 |
| Nickel, JC | 1 |
| McCormack, JJ | 1 |
4 review(s) available for quinazolines and Bacterial Disease
| Article | Year |
|---|---|
The Antibacterial Activity of Quinazoline and Quinazolinone Hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Humans; Quinazolines; Quinazolinones; Structure-Activity Relationship | 2022 |
Primary and secondary thrombocytosis in childhood.
Topics: Adolescent; Bacterial Infections; Blood Platelets; Child; Child, Preschool; Humans; Hydroxyurea; Infant; Infant, Newborn; Liver; Megakaryocytes; Mutation; Nucleic Acid Synthesis Inhibitors; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Thrombocytosis; Thrombopoiesis; Thrombopoietin; Virus Diseases | 2005 |
Role of alpha1-blockers in chronic prostatitis syndromes.
Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Ejaculation; Humans; Male; Pelvic Pain; Prostatism; Prostatitis; Quality of Life; Quinazolines; Randomized Controlled Trials as Topic; Secondary Prevention; Syndrome | 2008 |
Dihydrofolate reductase inhibitors as potential drugs.
Topics: Aminopterin; Animals; Antimalarials; Bacterial Infections; Biological Transport; Drug Interactions; Folic Acid; Folic Acid Antagonists; Helminthiasis; Humans; Immunosuppressive Agents; Leukemia, Experimental; Liver; Methotrexate; Mice; Mycoses; Neoplasms; Protozoan Infections; Psoriasis; Quinazolines; Rats; Receptors, Drug; Trypanosoma cruzi | 1981 |
5 other study(ies) available for quinazolines and Bacterial Disease
| Article | Year |
|---|---|
Synthesis and antimicrobial activity of polyhalobenzonitrile quinazolin-4(3H)-one derivatives.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Bacterial Infections; Candida albicans; Candidiasis; Humans; Microbial Sensitivity Tests; Quinazolines | 2013 |
1-R-2-([1,2,4]Triazolo[1,5-c]quinazoline-2-ylthio)etanon(ol)s: Synthesis, Bioluminescence Inhibition, Molecular Docking Studies, Antibacterial and Antifungal Activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Fungi; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycoses; Quinazolines; Tetrahydrofolate Dehydrogenase; Triazoles | 2016 |
Novel substituted hydrazono indolo[2,1-b]quinazoline-6,12-dione analogues as cytostatic agents: Synthesis, crystal structure, biological evaluation and molecular docking studies.
Topics: A549 Cells; Anti-Infective Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Fungi; HEK293 Cells; HeLa Cells; Humans; Hydrazones; Indoleamine-Pyrrole 2,3,-Dioxygenase; MCF-7 Cells; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycoses; Quinazolines; Structure-Activity Relationship | 2016 |
Synthesis and biological activity of novel N-cycloalkyl-(cycloalkylaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides.
Topics: Acetamides; Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Microbial Sensitivity Tests; Neoplasms; Quinazolines | 2011 |
Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome.
Topics: Adrenergic alpha-Antagonists; Adult; Androgen Antagonists; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Middle Aged; Plant Extracts; Prostatitis; Quinazolines; Serenoa; Treatment Outcome | 2007 |